SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells

SIMPLE SUMMARY: Resistance to oxaliplatin remains a major challenge in pancreatic cancer therapy. However, molecular mechanisms underlying oxaliplatin resistance in pancreatic cancer is still unclear. The aim of this study was to identify global changes of proteins involved in oxaliplatin resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Eun, Kim, Eun-Kyung, Song, Min-Jeong, Kim, Tae-Young, Jang, Ho Hee, Kang, Dukjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916634/
https://www.ncbi.nlm.nih.gov/pubmed/33578797
http://dx.doi.org/10.3390/cancers13040724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916634/
https://www.ncbi.nlm.nih.gov/pubmed/33578797
http://dx.doi.org/10.3390/cancers13040724

Ejemplares similares